Results 101 to 110 of about 13,974 (221)

Randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of three doses of co-suspension delivery technology glycopyrronium MDI in Japanese patients with moderate-to-severe COPD

International Journal of COPD, 2018
Yasushi Fukushima,1 Yuji Nakatani,2 Yumiko Ide,3 Hisakuni Sekino,4 Earl St Rose,5 Shahid Siddiqui,6 Andrea Maes,5 Colin Reisner5,6 1Department of Internal Medicine, Fukuwa Clinic, Tokyo, Japan; 2Department of Internal Medicine, Nakatani Hospital, Hyogo,
Fukushima Y, Nakatani Y, Ide Y, Sekino H, St Rose E, Siddiqui S, Maes A, Reisner C   +7 more
doaj  

Efficacy of tiotropium and olodaterol combination therapy on dynamic lung hyperinflation evaluated by hyperventilation in COPD: an open-label, comparative before and after treatment study

International Journal of COPD, 2019
Shohei Kawachi,1 Keisaku Fujimoto21Department of Biomedical Laboratory Science, Graduate School of Medicine, Shinshu University, Nagano 390-8621, Japan; 2Department of Clinical Laboratory Sciences, Shinshu University School of Health Sciences, Matsumoto ...
Kawachi S, Fujimoto K
doaj  

Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD

International Journal of COPD, 2016
Peter M Calverley,1 Göran Eriksson,2 Christine R Jenkins,3 Antonio R Anzueto,4 Barry J Make,5 Anders Persson,6 Malin Fagerås,6 Dirkje S Postma7 1Pulmonary and Rehabilitation Research Group, University Hospital Aintree, Liverpool, UK ...
Calverley PM, Eriksson G, Jenkins CR, Anzueto AR, Make BJ, Persson A, Fagerås M, Postma DS   +7 more
doaj  

Cardiovascular morbidity and the use of inhaled bronchodilators

International Journal of COPD, 2008
Christine Macie, Kate Wooldrage, Jure Manfreda, Nicholas AnthonisenDepartment of Medicine, University of Manitoba, Winnipeg, Manitoba, CanadaAbstract: We used the Manitoba Health database to examine the relationship between use of inhaled respiratory ...
Christine Macie, Kate Wooldrage, Jure Manfreda, Nicholas Anthonisen   +3 more
doaj  

[Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'] [PDF]

, 2003
Contains fulltext : 123542.pdf (Publisher’s version ) (Closed access)Apart from avoiding airway-irritating agents, the most important issue in the treatment of asthma is the suppression of airway inflammation by pharmaceutical treatment.
Diamant, Z., Dekhuijzen, P.N.R.
core  

Orbital and Systemic Myositis [PDF]

, 1995
Headache; DiplopiaA 56-year old male with progressive inflammation of the medial aspect of the right upper arm. A month later, after treatment with antibiotics, a dull ache and vertical diplopia OD.
Thomas R. Hedges III, MD; Jane B. Ward, MD
core  

Reducing cholinergic constriction: the major reversible mechanism in COPD

European Respiratory Review, 2006
The airway narrowing in chronic obstructive pulmonary disease (COPD) has often been misunderstood as being irreversible. However, a large proportion of patients with COPD do respond to bronchodilator agents with significant changes in lung function ...
V. Brusasco
doaj  

Novel methodology to characterise how asthma and chronic obstructive pulmonary disease patients use their inhalers and methods to improve their inhaler technique Objective assessment of how patients use inhalers [PDF]

Inhaled administration is the mainstay of asthma and chronic obstructive pulmonary disease (COPD) management using either a pressurised metered dose inhaler (pMDI) or a dry powder inhaler (DPI).
Azouz, Wahida Ahmed Abugrara
core  

Methacholine challenge testing: comparative pharmacology

Journal of Asthma and Allergy, 2018
Beth E Davis, Christianne M Blais, Donald W Cockcroft Division of Respirology, Critical Care and Sleep Medicine, Department of Medicine, University of Saskatchewan, Saskatoon, SK, Canada Abstract: Standardization of the methacholine inhalation challenge,
Davis BE, Blais CM, Cockcroft DW
doaj  

Asthma-like bronchodilator responsiveness in patients with neuronal intranuclear inclusion disease. [PDF]

Sci Rep
Tahara D, Tahara N, Tamai C, Akagi A, Riku Y, Miyahara H, Kobayashi R, Okada H, Kawamoto M, Ishii J, Yamazaki H, Kurashige T, Sugiyama A, Nagaishi A, Nishida K, Sugie K, Fukudome T, Hasegawa K, Ishiura H, Koike H, Kasai T, Mizuno T, Ando M, Higuchi Y, Tanaka F, Izumi Y, Sobue G, Iwasaki Y, Ito S, Sone J, Japanese Consortium for Neuronal Intranuclear Inclusion Disease Study (JaNIIDS) Group.   +30 more
europepmc   +1 more source